EXCLUSIVE LICENSE Between Adaptive Phage Therapeutics, Inc. And UNITED STATES OF AMERICA As Represented By THE SECRETARY OF THE NAVYWhereas Licensee • April 4th, 2024 • BiomX Inc. • Biological products, (no disgnostic substances)
This exclusive License (hereinafter called “LICENSE”) is made and entered into by and between the United States of America as represented by the Secretary of the Navy (hereinafter called “LICENSOR”) and
